Keymed Biosciences Inc KEYBF
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- $0.01 / $4,008.49
- Shares Outstanding
- 294.60M
- Market Cap
- —
- Volume/Avg
- 33,500 / 33,500
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Keymed Biosciences Inc is a biotechnology company with multiple clinical-stage assets. The company is focused on the in-house discovery and development of biological therapies that address large underserved medical needs in the autoimmune and oncology therapeutic areas. Its clinical-stage drug candidates include CM310, CM326, CM313, and CM336 among others. The company is engaged in biopharmaceutical research and development, which is regarded as a single reportable segment. Geographically, it generates a majority of its revenue from overseas markets and the rest from Mainland China.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 1,768
- Website
- https://www.keymedbio.com
Valuation
Metric | KEYBF |
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric | KEYBF |
|---|---|
Quick Ratio | 4.21 |
Current Ratio | 4.83 |
Interest Coverage | 64.80 |
Quick Ratio
KEYBF
Profitability
Metric | KEYBF |
|---|---|
Return on Assets (Normalized) | 16.75% |
Return on Equity (Normalized) | 25.38% |
Return on Invested Capital (Normalized) | 19.05% |
Return on Assets
KEYBF
Biotechnology Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc VRTX | LOCK|m#K!sWD | LOCK|xzj% | $131B | |||
| Regeneron Pharmaceuticals Inc REGN | LOCK|>WL!X! | LOCK|%qK@ | $95B | |||
| Moderna Inc MRNA | LOCK|%CPp>g | LOCK|G^z | $79B | |||
| argenx SE ADR ARGX | LOCK|B&!Bq&y | LOCK|P> | $59B | |||
| BeOne Medicines Ltd ADR ONC | LOCK|lzD?M? | LOCK|Q&< | $45B | |||
| Royalty Pharma PLC Class A RPRX | LOCK|Mvn<&yw | LOCK|?KDMB | $30B | |||
| Incyte Corp INCY | LOCK|$t>$## | LOCK|Df# | $23B | |||
| BioNTech SE ADR BNTX | LOCK|CKvF&r | LOCK|hhN | $20B | |||
| Alnylam Pharmaceuticals Inc ALNY | LOCK|^Bs@lj@ | LOCK|$kym | $19B | |||
| BridgeBio Pharma Inc BBIO | LOCK|G>&Vzw | LOCK|#P | $15B |